Generation Bio Co.
GBIO · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $20 | $6 | $0 | $0 |
| % Growth | 236.9% | – | – | – |
| Cost of Goods Sold | $0 | $0 | $0 | $0 |
| Gross Profit | $20 | $6 | $0 | $0 |
| % Margin | 100% | 100% | – | – |
| R&D Expenses | $61 | $94 | $97 | $85 |
| G&A Expenses | $38 | $51 | $44 | $34 |
| SG&A Expenses | $38 | $51 | $44 | $34 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $63 | $0 | $0 | $0 |
| Operating Expenses | $162 | $144 | $141 | $119 |
| Operating Income | -$142 | -$139 | -$141 | -$119 |
| % Margin | -715.8% | -2,346.9% | – | – |
| Other Income/Exp. Net | $11 | $12 | $5 | -$0 |
| Pre-Tax Income | -$132 | -$127 | -$137 | -$119 |
| Tax Expense | $0 | $0 | $0 | $0 |
| Net Income | -$132 | -$127 | -$137 | -$119 |
| % Margin | -661.9% | -2,144.5% | – | – |
| EPS | -19.76 | -19.63 | -23.51 | -21.17 |
| % Growth | -0.7% | 16.5% | -11.1% | – |
| EPS Diluted | -19.76 | -19.63 | -23.51 | -21.17 |
| Weighted Avg Shares Out | 7 | 6 | 6 | 6 |
| Weighted Avg Shares Out Dil | 7 | 6 | 6 | 6 |
| Supplemental Information | – | – | – | – |
| Interest Income | $11 | $12 | $5 | $0 |
| Interest Expense | $0 | $0 | $5 | $0 |
| Depreciation & Amortization | $5 | $5 | $5 | $5 |
| EBITDA | -$74 | -$133 | -$136 | -$115 |
| % Margin | -373.3% | -2,257.8% | – | – |